Huntsman Corporation (HUN) Stock Price & Analysis
Huntsman Corporation (HUN) is trading at USD 8.76, up 0.46% today, as of October 23, 2026 at 17:28 UTC (US market open; quotes may be delayed), according to Nexqual market data.
HUN last closed at USD 8.72; today's session has ranged USD 8.53–9 on volume of 3,458,716 shares. Market capitalization is $1.54B, with a 52-week range of USD 7.3–16.09 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 17:28 UTC.
Also available as compact Markdown for AI agents: nexqual.com/HUN.md
Key facts (HUN)
- Last four reported quarters (through Jun 30, 2026): revenue $5.90B, net income -$180M (-3.1% margin), free cash flow -$9.0M (SEC filings).
- 2 of 80 tracked superinvestors hold HUN (13F, Q2 2026): 0 new, 1 added, 1 reduced, 0 unchanged.
- Insider open-market purchases, last ~7 months: 1 Form 4 filing, $981K; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Hold (mean 3.07 on a 1–5 scale) (15 analysts), mean target USD 10.29 (range 9–13).
- Total return with dividends: 1Y +3.2% vs S&P 500 +14.4%; 5Y -67.0% vs S&P 500 +77.0%.
- Next earnings: 2026-11-02, EPS estimate USD 0.07, revenue estimate $1.61B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (HUN)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $7.67B | $8.02B | $6.11B | $6.04B | $5.68B | $5.90B |
| Gross profit | $1.58B | $1.55B | $906M | $866M | $751M | — |
| Operating income | $731M | $672M | $84.0M | -$25.0M | -$131M | -$32.0M |
| Net income | $1.04B | $460M | $101M | -$189M | -$284M | -$180M |
| EPS (diluted) | $4.72 | $2.27 | $0.57 | -$1.10 | -$1.65 | — |
| Free cash flow | $626M | $642M | -$21.0M | $79.0M | $116M | -$9.0M |
| Gross margin | 20.7% | 19.3% | 14.8% | 14.3% | 13.2% | — |
| Operating margin | 9.5% | 8.4% | 1.4% | -0.4% | -2.3% | -0.5% |
| Net margin | 13.6% | 5.7% | 1.7% | -3.1% | -5.0% | -3.1% |
| Revenue growth | +41.5% | +4.6% | -23.8% | -1.2% | -5.8% | — |
| Cash + short-term investments | $1.04B | $654M | $540M | $340M | $429M | — |
| Total debt | $1.55B | $1.74B | $1.69B | $1.83B | $2.01B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (HUN)
P/S 0.3x · EV/EBITDA 12.4x · EV/Sales 0.6x · P/B 0.6x · FCF yield -0.59% · Earnings yield -11.72% · Dividend yield (paid, TTM) 5.92% · Net debt $1.74B · EV $3.28B
P/E at fiscal year-ends: Dec 2023 44.1x.
Superinvestors (SEC 13F-HR, Q2 2026) (HUN)
2 of 80 tracked investors hold HUN. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Richard Pzena | Pzena Investment Management | 0.16% | $54.8M | Reduced -11.3% |
| First Eagle Investment | First Eagle Investment Management | 0.02% | $11.6M | Added +42.1% |
Insider purchases (SEC Form 4, open-market, last ~7 months) (HUN)
1 purchase, $981K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-08-03 | Huntsman Peter R | Chairman, President & CEO | 100,000 | $981K | 9.81 | Too little history (no open-market trades in 2023 or 2024) |
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (HUN)
Consensus Hold (mean 3.07 on a 1–5 scale), 15 analysts; mean target USD 10.29 (low 9, high 13).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-13 | RBC Capital | Target lowered | Sector Perform | $10 → $9 |
| 2026-10-13 | Barclays | Initiated | Equal-Weight | $10 |
| 2026-10-06 | Wells Fargo | Target lowered | Equal-Weight | $11 → $9 |
| 2026-10-05 | UBS | Target lowered | Neutral | $10 → $9 |
| 2026-10-02 | Jefferies | Target lowered | Buy | $16 → $11 |
| 2026-09-30 | Citigroup | Target lowered | Neutral | $11 → $9 |
| 2026-09-11 | Keybanc | Initiated | Overweight | $14 |
| 2026-08-04 | Wells Fargo | Target lowered | Equal-Weight | $14 → $11 |
| 2026-08-03 | UBS | Target lowered | Neutral | $11 → $10 |
| 2026-08-03 | RBC Capital | Target lowered | Sector Perform | $11 → $10 |
| 2026-07-01 | Mizuho | Target lowered | Neutral | $14 → $13 |
| 2026-06-30 | B of A Securities | Target raised | Underperform | $10 → $11 |
Total return (dividends reinvested) (HUN)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +3.2% | -67.0% |
| S&P 500 (SPY) | +14.4% | +77.0% |
| Per year | +3.2% | -19.9% |
| Volatility (annualized) | 60.4% | 41.8% |
| Max drawdown | -48.7% (Jun 2026→Oct 2026) | -76.7% (Feb 2022→Oct 2025) |
HUN revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Polyurethanes | $1.08B | 64.4% | +15.8% |
| Advanced Materials | $313.0M | 18.7% | +18.6% |
| Performance Products | $283.0M | 16.9% | +4.8% |
| Total revenue | $1.68B | 100% | — |
HUN revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Diversified | $1.08B | 64.4% | +15.8% |
| Specialty | $300.0M | 17.9% | +19.0% |
| Product & Service Other | $13.0M | 0.8% | +8.3% |
| Total revenue | $1.68B | 100% | — |
HUN revenue by region (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| US & Canada | $658.0M | 39.3% | +17.1% |
| Asia Pacific | $448.0M | 26.7% | +10.3% |
| Europe | $441.0M | 26.3% | +14.0% |
| Rest Of World | $116.0M | 6.9% | +12.6% |
| Total revenue | $1.68B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
HUN suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | Chevron (CVX) | “Our amines customers include Afton, Bayer, Chevron, DuPont, Evonik, Hipower, Infineum, Lubrizol, Quadra Chemicals and Univar.” |
| Customer | DuPont (DD) | “Our amines customers include Afton, Bayer, Chevron, DuPont, Evonik, Hipower, Infineum, Lubrizol, Quadra Chemicals and Univar.” |
| Partner | LANXESS AG (LNXSY) | “Lanxess AG ("Lanxess") is our joint venture partner in Rubicon LLC ("Rubicon"), which owns aniline, nitrobenzene and DPA manufacturing facilities in Geismar, Louisiana.” |
| Partner | Rubicon | “Lanxess AG ("Lanxess") is our joint venture partner in Rubicon LLC ("Rubicon"), which owns aniline, nitrobenzene and DPA manufacturing facilities in Geismar, Louisiana.” |
| Partner | Huntsman Polyurethanes Shanghai | “Huntsman Polyurethanes Shanghai Ltd. ("HPS") is our splitting joint venture with Shanghai Chlor-Alkali Chemical Company, Ltd that manufactures pure MDI, polymeric MDI, MDI variants and formulated MDI systems.” |
| Competitor | 3M (MMM) | “Our major competitors include 3M, Henkel and Sumitomo.” |
Quoted from the company's 10-K filed Feb 18, 2026.
HUN company outlook (results filed Jul 30, 2026)
- “During 2026, we expect capital expenditures to be approximately $170 million.”
Quoted word-for-word from the SEC 8-K results press release.
HUN analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.07 | $0.07 | +1.8% | $1.61B | 14 |
| Next quarter (ends Dec 2026) | $-0.12 | $-0.13 | -8.8% | $1.46B | 14 |
| Current fiscal year (ends Dec 2026) | $-0.25 | $-0.18 | +34.8% | $6.16B | 14 |
| Next fiscal year (ends Dec 2027) | $0.24 | $0.19 | +24.6% | $6.28B | 9 |
Key Statistics (as of October 23, 2026 at 17:28 UTC)
| Price | USD 8.76 |
|---|---|
| Change | ▲ 0.46% (up) |
| Previous Close | USD 8.72 |
| Open | USD 8.58 |
| Day Range | USD 8.53 – 9 |
| 52-Week Range | USD 7.3 – 16.09 |
| Volume | 3,458,716 shares |
| Market Cap | $1.54B |
| Exchange | NYQ |
Technical Analysis (HUN)
Nexqual's technical model rates HUN "NEUTRAL" based on 2 bullish and 3 bearish signals across 128 daily candles, as of October 23, 2026 at 17:28 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 49.76 (neutral) |
| vs SMA50 | Below (USD 9.1) |
| MACD | -0.18 (negative) |
Analyst Ratings (HUN)
Wall Street analysts rate HUN "Hold" based on 15 analysts, with a mean price target of USD 10.29 (range USD 9–13), per Nexqual as of October 23, 2026 at 17:28 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 15 |
| Mean Target | USD 10.29 |
| High Target | USD 13 |
| Low Target | USD 9 |
| Buy / Hold / Sell | 2 / 11 / 2 |
Earnings (HUN)
| Next Earnings Date | 2026-11-02 |
|---|---|
| EPS Estimate | USD 0.07 |
| Revenue Estimate | $1.61B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0 vs est 0.06 ▼ miss |
| 2026-03-31 | USD -0.2 vs est -0.21 ▲ beat |
| 2025-12-31 | USD -0.37 vs est -0.31 ▼ miss |
| 2025-09-30 | USD -0.03 vs est -0.15 ▲ beat |
Source: Nexqual, October 23, 2026 at 17:28 UTC.
Financials & Fundamentals (HUN)
| Total Revenue | $5.90B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +14.10% |
| Gross Margin | +13.50% |
| Operating Margin | +1.74% |
| Profit Margin | -3.05% |
| ROE | -3.84% |
| Debt / Equity | 0.85 |
| Current Ratio | 1.33 |
| Total Cash | $346.00M |
| Total Debt | $2.50B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | -$9.00M (-0.2% of revenue) |
Source: Nexqual, October 23, 2026 at 17:28 UTC.
Financial Health Score (HUN)
Nexqual rates Huntsman Corporation's overall financial health "Weak" across five dimensions, as of October 23, 2026 at 17:28 UTC.
| Growth | Weak — Revenue -6% YoY (annual), declining |
|---|---|
| Profitability | Weak — Gross margin 13%, operating 2% (last 12 months) |
| Balance Sheet | Mixed — $346M cash and investments vs $2.09B debt (Jun 2026, SEC) |
| Cash Flow | Weak — FCF negative: -$9M (last 4 quarters to Jun 2026, SEC), burning cash |
| Efficiency | Critical — ROE -4%, ROA -0.0% |
Ownership (HUN)
| Insider Ownership | +5.95% |
|---|---|
| Institutional Ownership | +92.47% |
| Shares Outstanding | 175.38M |
| Float | 164.38M |
| Short % of Float | +7.29% |
Source: Nexqual, October 23, 2026 at 17:28 UTC.
Leadership (HUN)
Huntsman Corporation is led by Peter R. Huntsman, Chairman, President & CEO, per Nexqual as of October 23, 2026 at 17:28 UTC.
| Chairman, President & CEO | Peter R. Huntsman |
|---|---|
| Executive VP & CFO | Philip M. Lister ACMA |
| Division President of Advanced Materials | Scott J. Wright |
| Vice President of Investor Relations & Corporate Development | Ivan Mathew Marcuse C.F.A. |
| Division President of Polyurethanes | Steen Weien Hansen |
Major Backers & Investors (HUN)
Notable institutional backers of Huntsman Corporation include AQR Capital Management, LLC, American Century Companies Inc, Invesco, according to Nexqual as of October 23, 2026 at 17:28 UTC.
Active Investors
| Investor | Stake |
|---|---|
| AQR Capital Management, LLC | 4.97% |
| American Century Companies Inc | 4.33% |
| Invesco | 3.26% |
| Two Sigma Investments, LP | 3.16% |
| Pzena Investment Management LLC | 2.94% |
| AIM Sector Funds (Invesco Sector Funds)-Invesco Small Cap Value Fund | 2.86% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 10.4% |
| Vanguard Group | 9.51% |
| Dimensional Fund Advisors | 3.16% |
| State Street | 2.93% |
Source: Nexqual, October 23, 2026 at 17:28 UTC.
From Huntsman Corporation's Latest SEC 10-K Filing (filed 2026-02-18)
Key Strengths & Strategy (as disclosed to the SEC)
- Our global production capacity of MDI, polyols and TPU is approximately 2.9 billion pounds, 0.6 billion pounds and 0.1 billion pounds, respectively.
- Our SPF products offer significant environmental benefits, as our proprietary manufacturing process transforms raw material from low quality PET plastic bottles into highly effective energy-saving polyurethane insulation.
- Our strategy is focused on growing our differentiated product offering (differentiated MDI and polyols, formulated MDI-based systems and TPU), which requires a greater emphasis on formulating capability and technical solutions to help our downstream customers meet the desired effect required in their applications.
- We market our polyurethane chemicals to over 6,500 customers in more than 90 countries.
Legal & Regulatory Risks (Item 1A, quoted)
- We are subject to many EHS regulations that may result in unanticipated costs or liabilities, which could reduce our profitability.
- Additional new laws and regulations may be enacted or adopted by various regulatory agencies globally.
- We could incur significant expenditures in order to comply with existing or future EHS laws.
- Regulatory requirements to reduce GHG or other emissions could have an adverse effect on our results of operations.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| REX | REX American Resources Corporat | USD 39.51 | ▼ 0.79% |
| OLN | Olin Corporation | USD 15.59 | ▲ 0.32% |
| GPRE | Green Plains, Inc. | USD 14.05 | ▲ 0.98% |
| WLKP | Westlake Chemical Partners LP | USD 21.1 | ▲ 0.67% |
| LXU | LSB Industries, Inc. | USD 9.92 | ▲ 1.64% |
| BAK | Braskem SA | USD 1.64 | ▲ 2.19% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 17:28 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt